Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Araclon Biotech S.L.
DescriptionTest for beta amyloid 40 and 42
Molecular Target Beta amyloid
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationNeurology, Diagnostic
Indication DetailsDiagnose Alzheimer's disease (AD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today